Children and teens prescribed GLP-1 medications for weight loss, prediabetes, or type 2 diabetes face a 16.8% risk of being diagnosed with nutritional deficiencies within their first year of treatment, according to a study published in the journal Childhood Obesity. Researchers at Ann & Robert H. Lurie Children’s Hospital of Chicago analyzed national insurance claims data and found that vitamin D deficiency impacted 12.4% of pediatric patients, highlighting a critical gap in proactive nutritional monitoring during adolescent growth phases.
Pediatric GLP-1 Usage and Nutritional Deficiencies
As pediatric prescriptions for glucagon-like peptide-1 receptor agonists continue to rise, medical providers face new challenges regarding adolescent development. According to Dr. Justin Ryder, senior author of the study and Vice Chair of Research for the Department of Surgery at Lurie Children’s Hospital, nutrient monitoring is essential during rapid growth periods. Adolescents require steady intakes of vitamin D, iron, and calcium to support proper skeletal development and overall health.
The study reviewed national administrative claims data from 2017 to 2022 across more than 100 million patients. Researchers identified 2,031 patients aged 10 to 17 who maintained continuous enrollment and had no history of nutritional deficiencies prior to starting GLP-1 therapy. Liraglutide was the most frequently prescribed medication in this cohort at 78.6%, followed by dulaglutide at 10.4% and semaglutide at 9.1%.
Did you know? While nearly one in six pediatric patients developed a deficiency within a year, the study revealed that only 5% received nutritional counseling within the first 30 days of treatment, and fewer than 25% received counseling within six months.
Proactive Nutritional Management in Adolescents
Preventing nutrient shortfalls requires clinical intervention well before bloodwork reveals a deficiency. Dr. Ryder emphasized that nutritional support needs to play an active role the moment a physician initiates GLP-1 therapy. Waiting for a clinical diagnosis of a vitamin or mineral shortage leaves young patients vulnerable during pivotal developmental years.
Frequently Asked Questions
What are the most common nutritional deficiencies linked to GLP-1s in children?
Vitamin D deficiency is the most frequently diagnosed issue, affecting 12.4% of pediatric patients within the first year of treatment, according to the Childhood Obesity study.
Why are adolescents particularly at risk for nutrient deficiencies on these medications?
Adolescence is a period of rapid growth and pubertal development where the body demands higher levels of key nutrients like calcium, iron, and vitamin D to support skeletal and overall health.
How quickly do children receive nutritional counseling after starting a GLP-1?
Data shows that only 5% of pediatric patients receive nutritional counseling within 30 days of starting treatment, and less than 25% receive counseling within six months.
Which GLP-1 medications were most commonly prescribed to the study’s pediatric cohort?
Liraglutide accounted for 78.6% of prescriptions in the study group, followed by dulaglutide at 10.4% and semaglutide at 9.1%.
Join the Discussion: Have you or your family discussed nutritional planning with a pediatrician regarding GLP-1 therapies? Share your thoughts or questions in the comments below, and subscribe to our newsletter for the latest updates on pediatric healthcare research.
Keep reading